Schneeweiss, Sebastian

Variable Selection for Propensity Score Models

Brookhart, M. A., Schneeweiss, S., Rothman, K. J., Glynn, R. J., Avorn, J., & Stürmer, T. (2006) · American Journal of Epidemiology

Advanced Causal Inference TechniquesStatistical Methods in Epidemiology

Cited by 2,336

High-dimensional propensity score adjustment in studies of treatment effects using health care claims data.

Schneeweiss, S., Rassen, J. A., Glynn, R. J., Avorn, J., Mogun, H., & Brookhart, M. A. (2009) · Epidemiology

Advanced Causal Inference TechniquesStatistical Methods in Epidemiology

Cited by 1,128

A combined comorbidity score predicted mortality in elderly patients better than existing scores

Gagne, J. J., Glynn, R. J., Avorn, J., Levin, R., & Schneeweiss, S. (2011) · Journal of Clinical Epidemiology

Chronic Disease Management StrategiesFrailty in Older Adults

Cited by 995

Risk of Death in Elderly Users of Conventional vs. Atypical Antipsychotic Medications

Wang, P. S., Schneeweiss, S., Avorn, J., Fischer, M. A., Mogun, H., Solomon, D. H., & Brookhart, M. A. (2005) · New England Journal of Medicine

Schizophrenia research and treatmentPharmaceutical Practices and Patient Outcomes

Cited by 959

Network-based approach to prediction and population-based validation of in silico drug repurposing

Cheng, F., Desai, R. J., Handy, D. E., Wang, R., Schneeweiss, S., Barabási, A.-L., & Loscalzo, J. (2018) · Nature Communications

Computational Drug Discovery MethodsBioinformatics and Genomic Networks

Cited by 552

Indications for propensity scores and review of their use in pharmacoepidemiology

Glynn, R. J., Schneeweiss, S., & Stürmer, T. (2006) · Basic & Clinical Pharmacology & Toxicology

Advanced Causal Inference TechniquesStatistical Methods in Epidemiology

Cited by 541

Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients

Schneeweiss, S., Setoguchi, S., Brookhart, A., Dormuth, C., & Wang, P. S. (2007) · Canadian Medical Association Journal

Schizophrenia research and treatmentPharmaceutical Practices and Patient Outcomes

Cited by 366

Risk of diabetic ketoacidosis after initiation of an SGLT2 inhibitor

Fralick, M., Schneeweiss, S., & Patorno, E. (2017) · New England Journal of Medicine

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 334

When and how can real world data analyses substitute for randomized controlled trials?

Franklin, J. M., & Schneeweiss, S. (2017) · Clinical Pharmacology & Therapeutics

Advanced Causal Inference TechniquesStatistical Methods in Clinical Trials

Cited by 316

Validation of a Claims-Based Frailty Index Against Physical Performance and Adverse Health Outcomes in the Health and Retirement Study

Kim, D. H., Glynn, R. J., Avorn, J., Lipsitz, L. A., Rockwood, K., Pawar, A., & Schneeweiss, S. (2019) · The Journals of Gerontology: Series A

Frailty in Older AdultsChronic Disease Management Strategies

Cited by 285

A basic study design for expedited safety signal evaluation based on electronic healthcare data

Schneeweiss, S. (2010) · Pharmacoepidemiology and Drug Safety

Pharmacovigilance and Adverse Drug ReactionsStatistical Methods in Clinical Trials

Cited by 255

Empagliflozin and the Risk of Heart Failure Hospitalization in Routine Clinical Care: A First Analysis From the EMPRISE Study

Patorno, E., Pawar, A., Franklin, J. M., Najafzadeh, M., Déruaz-Luyet, A., Brodovicz, K. G., Sambevski, S., Bessette, L. G., Santiago Ortiz, A. J., Kulldorff, M., et al. (2019) · Circulation

Diabetes Treatment and ManagementHeart Failure Treatment and Management

Cited by 215

Bone mineral density in subjects using central nervous system-active medications

Kinjo, M., Setoguchi, S., Schneeweiss, S., & Solomon, D. H. (2005) · The American Journal of Medicine

Bone health and osteoporosis researchPharmaceutical Practices and Patient Outcomes

Cited by 191

Veteran’s affairs hospital discharge databases coded serious bacterial infections accurately

Schneeweiss, S., Robicsek, A., Scranton, R., Zuckerman, D., & Solomon, D. H. (2007) · Journal of Clinical Epidemiology

Medical Coding and Health InformationInfection Control in Healthcare

Cited by 178

Instrumental variables I: instrumental variables exploit natural variation in nonexperimental data to estimate causal relationships

Rassen, J. A., Brookhart, M. A., Glynn, R. J., Mittleman, M. A., & Schneeweiss, S. (2009) · Journal of Clinical Epidemiology

Advanced Causal Inference TechniquesStatistical Methods in Clinical Trials

Cited by 164

Sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists and the risk for cardiovascular outcomes in routine care patients with diabetes across categories of cardiovascular disease

Patorno, E., Htoo, P. T., Glynn, R. J., Schneeweiss, S., Wexler, D. J., Pawar, A., Bessette, L. G., Chin, K., Everett, B. M., & Kim, S. C. (2021) · Annals of Internal Medicine

Diabetes Treatment and ManagementHeart Failure Treatment and Management

Cited by 103

Glucagon-like peptide-1 receptor agonists and hepatic decompensation events in patients with cirrhosis and diabetes

Simon, T. G., Patorno, E., & Schneeweiss, S. (2022) · Clinical Gastroenterology and Hepatology

Diabetes Treatment and ManagementLiver Disease and Transplantation

Cited by 98

Trends in clinical characteristics and prescribing preferences for SGLT2 inhibitors and GLP-1 receptor agonists, 2013-2018.

Dave, C. V., Schneeweiss, S., Wexler, D. J., Brill, G., & Patorno, E. (2020) · Diabetes Care

Diabetes Treatment and ManagementHeart Failure Treatment and Management

Cited by 97

Validation of obesity‐related diagnosis codes in claims data

Suissa, K., Schneeweiss, S., Lin, K. J., Brill, G., Kim, S. C., & Patorno, E. (2021) · Diabetes, Obesity and Metabolism

Medical Coding and Health InformationObesity, Physical Activity, Diet

Cited by 89

Semaglutide and Tirzepatide in Patients With Heart Failure With Preserved Ejection Fraction

Krüger, N., Schneeweiss, S., Fuse, K., Matseyko, S., Sreedhara, S. K., Hahn, G., Schunkert, H., & Wang, S. V. (2025) · JAMA

Heart Failure Treatment and ManagementDiabetes Treatment and Management

Cited by 66

Risk of amputation with canagliflozin across categories of age and cardiovascular risk in three US nationwide databases: cohort study

Fralick, M., Kim, S. C., Schneeweiss, S., Everett, B. M., Glynn, R. J., & Patorno, E. (2020) · BMJ

Diabetes Treatment and ManagementDiabetic Foot Ulcer Assessment and Management

Cited by 63

Design considerations in an active medical product safety monitoring system.

Gagne, J. J., Fireman, B., Ryan, P. B., Maclure, M., Gerhard, T., Toh, S., Rassen, J. A., Nelson, J. C., & Schneeweiss, S. (2012) · Pharmacoepidemiology and Drug Safety

Pharmacovigilance and Adverse Drug ReactionsAdvanced Causal Inference Techniques

Cited by 49

Cardiovascular outcomes of semaglutide and tirzepatide for patients with type 2 diabetes in clinical practice

Krüger, N., Schneeweiss, S., Desai, R. J., Sreedhara, S. K., Kehoe, A. R., Fuse, K., Hahn, G., Schunkert, H., & Wang, S. V. (2026) · Nature Medicine

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 48

Comparative risk of alzheimer disease and related dementia among Medicare beneficiaries with rheumatoid arthritis treated with targeted disease-modifying antirheumatic agents

Desai, R. J., Varma, V. R., Gerhard, T., Segal, J., Mahesri, M., Chin, K., Horton, D. B., Kim, S. C., Schneeweiss, S., & Thambisetty, M. (2022) · JAMA Network Open

Rheumatoid Arthritis Research and TherapiesDementia and Cognitive Impairment Research

Cited by 45